Pasar al contenido principal

DESARROLLO DE NUEVOS ABORDAJES DE VACUNACION MUCOSAL Y PARENTERAL FRENTE A LA TUBERCULOSIS ANIMAL Y EVALUACION DE SUS EFECTOS EN LOS MODELOS DE TUBERCULOSIS INTRANASAL DE RATO

PID2022-142939OR-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario NEIKER-INSTITUTO VASCO DE INVESTIGACION Y DESARROLLO AGRARIO SA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

A humoral diagnostic test outperforms cellular tests in a farm with a latent tuberculosis outbreak caused by a new Mycobacterium tuberculosis complex spoligotype that affected sheep but not goats

  • Juste, Ramón Antonio
  • Fernández Veiga, Leire
  • Fuertes Franco, Miguel
  • Fernández-Ortiz de Murua, Ignacio
  • Cardona, Guillermo
  • Geijo, María V.
  • Garrido, Joseba M.
  • Sevilla, Iker A.
[EN] Tuberculosis (TB) is a disease caused by members of the M. tuberculosis complex (MTC) that affects numerous species. M. caprae, a member of the complex which is close to M. bovis, is emerging and affects several different hosts that include goats, cattle, sheep, pigs, rabbits, wild boar, red deer, foxes and also humans. A new M. caprae spoligotype (SB2737) was isolated from an outbreak of sheep tuberculosis affecting a mixed sheep (323)-goat (29) farm in 2021. The index case was detected by the La Rioja slaughterhouse veterinary inspection. Tracing back to the farm of origin, both species were submitted to Comparative Intradermal Tuberculin Test (CITT) and M. bovis-specific antibody ELISA tests. A subsample was also examined by IFN-γ release assay (IGRA) and all positives were slaughtered and pathologically and microbiologically investigated. Only 1.2% of sheep and no goat were positive in the CITT, and 11.4% in the IGRA sheep subsample, while up to 36.8% were positive in two consecutive M. bovis-specific antibody ELISA tests. Goats had always tested negative in annual intradermal follow-up since 2013. Upon confirmation of the immunologically positive sheep at slaughter, all the remaining negative animals were killed and 29.2% of sheep were still found infected. This raised the final overall prevalence to 37.5%. Antibody ELISA was the most sensitive (81.4%) in vivo detection method still showing a 85.0% specificity relative to pathological and microbiological tuberculosis status. It was nearly 10 times more sensitive than skin test and had an 86.8% positive predictive value. Notwithstanding a possible singular pathogenesis of the new spoligotype, this outbreak adds up to previous reports suggesting that sheep tuberculosis could be huge reservoir of infection worldwide overlooked by skin test low sensitivity or simply lack of investigation. This makes it urgent to extend the use antibody tests to address the Trojan horse of hidden M. tuberculosis complex infections on bovine TB control programs., SI, The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study has been carried out partly with funds from Grant PID2019-105155RB-C33 and Grant PID2022-142939OR-C21 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe.”
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Protection and diagnostic interference induced by heat-inactivated, phage-inactivated and live vaccine prototypes against animal tuberculosis

  • Fernández Veiga, Leire
  • Fuertes Franco, Miguel
  • Geijo, María V.
  • Elguezabal, Natalia
  • Serrano Mestre, José Luis
  • Vázquez Iniesta, Lucía
  • Prados Rosales, Rafael
  • Michelet, Lorraine
  • Boschiroli, Maria Laura
  • Pérez de Val, Bernat
  • Jones, Gareth J.
  • Juste, Ramón A.
  • Garrido, Joseba M.
  • Sevilla, Iker A.
Introduction: Vaccination emerges as a promising cost-effective tool to reduce the impact and spread of animal tuberculosis, especially in regions where test-and-slaughter eradication strategy is socioeconomically unfeasible or unfruitful for different reasons, provided it is safe, efficacious and compatible with diagnosis. Methods: In this study, we preliminarily evaluated the diagnostic interference (using guinea pigs) and the protective efficacy (using mice) of three heat-inactivated, three phage-inactivated and one live attenuated vaccine prototypes prepared from M. bovis, M. caprae, and M. microti. Results and discussion: Phage-inactivation killed almost all (96.41–99.92%) bacteria to be included in vaccines and filtering was used to remove the remaining viable cells. All the assayed vaccines induced skin test reactions in response to bovine tuberculin, but they were smaller in the phage-inactivated vaccine groups. All the vaccines were diagnosis-compatible with defined skin test antigens based on ESAT-6, CFP-10, and Rv3615c. In contrast with the rest of prototypes, vaccination with heat- and phage-inactivated M. microti did not prompt the production of detectable anti-MPB70+MPB83 antibodies. Mean bacterial burden was lower in all vaccinated groups in comparison with the control, being significantly reduced in the lungs of the heat-inactivated M. microti and M. caprae and phage-inactivated M. caprae groups. Considering both diagnostic interference and protection collectively, the heat-inactivated M. microti vaccine showed the best performance. Further studies to evaluate these vaccines and to improve phage-driven inactivation are warranted, SI, The author(s) declare that financial support was received for the research and/or publication of this article. This study has been carried out with funds from Grants PID2019- 105155RB-C33 and PID2022-142939OR-C21 funded by MCIN/AEI/10.13039/501100011033 and by ERDF/EU, and Grant EFA115/01 INNOTUB II funded by the INTERREG POCTEFA 2021–2027 Program (co-funded by the European Union). LF-V holds a pre-doctoral fellowship from the Department of Economic Development, Sustainability and Environment of the Basque Government. RP-R thanks support from grants NIH RO1AI162821 and Spanish MICINN contracts PID2019-110240RB-I00 and PID2022-136611OB-I00
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Protection and diagnostic interference induced by heat-inactivated, phage-inactivated and live vaccine prototypes against animal tuberculosis

  • Fernández Veiga, Leire
  • Fuertes, Miguel
  • Geijo, María V.
  • Elguezabal, Natalia
  • Serrano-Mestre, Jose L.
  • Vázquez-Iniesta, Lucía
  • Prados-Rosales, Rafael
  • Michelet, Lorraine
  • Boschiroli, Maria Laura
  • Pérez de Val, Bernat
  • Jones, Gareth J.
  • Juste, Ramón A.
  • Garrido, Joseba M.
  • Sevilla, Iker A.
Introduction: Vaccination emerges as a promising cost-eective tool to reduce the impact and spread of animal tuberculosis, especially in regions where testand-slaughter eradication strategy is socioeconomically unfeasible or unfruitful for dierent reasons, provided it is safe, e cacious and compatible with diagnosis. Methods: In this study, we preliminarily evaluated the diagnostic interference (using guinea pigs) and the protective e cacy (using mice) of three heatinactivated, three phage-inactivated and one live attenuated vaccine prototypes prepared from M. bovis, M. caprae, and M. microti. Results and discussion: Phage-inactivation killed almost all (96.41–99.92%) bacteria to be included in vaccines and filtering was used to remove the remaining viable cells. All the assayed vaccines induced skin test reactions in response to bovine tuberculin, but they were smaller in the phage-inactivated vaccine groups. All the vaccines were diagnosis-compatible with defined skin test antigens based on ESAT-6, CFP-10, and Rv3615c. In contrast with the rest of prototypes, vaccination with heat- and phage-inactivated M. microti did not prompt the production of detectable anti-MPB70+MPB83 antibodies. Mean bacterial burden was lower in all vaccinated groups in comparison with the control, being significantly reduced in the lungs of the heat-inactivated M. microti and M. caprae and phage-inactivated M. caprae groups. Considering both diagnostic interference and protection collectively, the heat-inactivated M. microti vaccine showed the best performance. Further studies to evaluate these vaccines and to improve phage-driven inactivation are warranted., The author(s) declare that financial support was received for the research and/or publication of this article. This study has been carried out with funds from Grants PID2019-105155RB-C33 and PID2022-142939OR-C21 funded by MCIN/AEI/10.13039/501100011033 and by ERDF/EU, and Grant EFA115/01 INNOTUB II funded by the INTERREG POCTEFA 2021–2027 Program (co-funded by the European Union). LF-V holds a pre-doctoral fellowship from the Department of Economic Development, Sustainability and Environment of the Basque Government. RP-R thanks support from grants NIH RO1AI162821 and Spanish MICINN contracts PID2019-110240RB-I00 and PID2022-136611OB-I00., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Protection and diagnostic interference induced by heat-inactivated, phage-inactivated and live vaccine prototypes against animal tuberculosis

  • Fernández Veiga, Leire
  • Fuertes, Miguel
  • Geijo, María V.
  • Elguezabal, Natalia
  • Serrano-Mestre, Jose L.
  • Vázquez-Iniesta, Lucía
  • Prados-Rosales, Rafael
  • Michelet, Lorraine
  • Boschiroli, Maria Laura
  • Pérez de Val, Bernat
  • Jones, Gareth J.
  • Juste, Ramón A.
  • Garrido, Joseba M.
  • Sevilla, Iker A.
Introduction: Vaccination emerges as a promising cost-eective tool to reduce the impact and spread of animal tuberculosis, especially in regions where testand-slaughter eradication strategy is socioeconomically unfeasible or unfruitful for dierent reasons, provided it is safe, e cacious and compatible with diagnosis. Methods: In this study, we preliminarily evaluated the diagnostic interference (using guinea pigs) and the protective e cacy (using mice) of three heatinactivated, three phage-inactivated and one live attenuated vaccine prototypes prepared from M. bovis, M. caprae, and M. microti. Results and discussion: Phage-inactivation killed almost all (96.41–99.92%) bacteria to be included in vaccines and filtering was used to remove the remaining viable cells. All the assayed vaccines induced skin test reactions in response to bovine tuberculin, but they were smaller in the phage-inactivated vaccine groups. All the vaccines were diagnosis-compatible with defined skin test antigens based on ESAT-6, CFP-10, and Rv3615c. In contrast with the rest of prototypes, vaccination with heat- and phage-inactivated M. microti did not prompt the production of detectable anti-MPB70+MPB83 antibodies. Mean bacterial burden was lower in all vaccinated groups in comparison with the control, being significantly reduced in the lungs of the heat-inactivated M. microti and M. caprae and phage-inactivated M. caprae groups. Considering both diagnostic interference and protection collectively, the heat-inactivated M. microti vaccine showed the best performance. Further studies to evaluate these vaccines and to improve phage-driven inactivation are warranted., The author(s) declare that financial support was received for the research and/or publication of this article. This study has been carried out with funds from Grants PID2019-105155RB-C33 and PID2022-142939OR-C21 funded by MCIN/AEI/10.13039/501100011033 and by ERDF/EU, and Grant EFA115/01 INNOTUB II funded by the INTERREG POCTEFA 2021–2027 Program (co-funded by the European Union). LF-V holds a pre-doctoral fellowship from the Department of Economic Development, Sustainability and Environment of the Basque Government. RP-R thanks support from grants NIH RO1AI162821 and Spanish MICINN contracts PID2019-110240RB-I00 and PID2022-136611OB-I00., info:eu-repo/semantics/publishedVersion